SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

In recent years, the rate of cardiovascular mortality following high-risk myocardial infarction has significantly declined.

De-escalating dual antiplatelet therapy from from aspirin plus ticagrelor to aspirin plus clopidogrel after primary ...

Research has linked higher levels of air pollution to the risk of acute myocardial infarctions, or heart attacks. How these ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

95% CI 1.07 to 1.43), but a similar risk for myocardial infarction (MI) compared with the reference group. Patients with T1MI had a lower adjusted risk of death (0.86, 95% CI 0.74 to 1.00) and higher ...

Posterior cortical atrophy (PCA) is caused by damage that builds up in the brain cells at the back of the brain. This is the part of our brain that processes information from our eyes, and allows us ...

A cerebrovascular accident (CVA) is a medical term that refers to types of strokes. In a CVA, blood flow to the brain is interrupted. Signs of a CVA may include weakness, numbness, confusion, or loss ...